Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.45 is 16% below its 5-year average of 6.46, near the low end of its 5-year range (5.06–10.81).
As of the fiscal period ended Tuesday, June 30, 2026. 17.63% below its 12-month average of 6.62.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.45.
QUICK RATIO (ACID-TEST)
5.45
QUICK RATIO (ACID-TEST) AVG TTM
6.62
QUICK RATIO (ACID-TEST) AVG 3Y
5.78
QUICK RATIO (ACID-TEST) AVG 5Y
6.46
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-17.63%
CURRENT VS 3Y AVG
-5.70%
CURRENT VS 5Y AVG
-15.69%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 526 covered companies
CURRENT VS SECTOR MEDIAN
+82.24%
vs the sector median at left
C4 Therapeutics, Inc.
Market Cap
$329.49M
Quick Ratio (Acid-Test)
5.45
TTM Avg
6.62
3Y Avg
5.78
5Y Avg
6.46
Market Cap
$334.26M
Quick Ratio (Acid-Test)
5.79
TTM Avg
4.46
3Y Avg
8.92
5Y Avg
12.08
Market Cap
$339.93M
Quick Ratio (Acid-Test)
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
Market Cap
$318.27M
Quick Ratio (Acid-Test)
2.44
TTM Avg
4.94
3Y Avg
7.05
5Y Avg
7.05
Market Cap
$348.85M
Quick Ratio (Acid-Test)
1.68
TTM Avg
1.66
3Y Avg
1.70
5Y Avg
1.47
Market Cap
$311.25M
Quick Ratio (Acid-Test)
34.00
TTM Avg
44.34
3Y Avg
25.02
5Y Avg
19.51
Market Cap
$348.63M
Quick Ratio (Acid-Test)
3.87
TTM Avg
3.84
3Y Avg
4.42
5Y Avg
6.10
Market Cap
$305.38M
Quick Ratio (Acid-Test)
8.80
TTM Avg
4.55
3Y Avg
3.67
5Y Avg
2.92
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $329.49M | 5.45 | 6.62 | 5.78 | 6.46 |
| Cabaletta Bio, Inc. (CABA)vs › | $334.26M | 5.79 | 4.46 | 8.92 | 12.08 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $339.93M | 24.16 | 12.00 | 8.65 | 7.93 |
| CapsoVision, Inc. (CV)vs › | $318.27M | 2.44 | 4.94 | 7.05 | 7.05 |
| Embecta Corp. (EMBC)vs › | $348.85M | 1.68 | 1.66 | 1.70 | 1.47 |
| Benitec Biopharma Inc. (BNTC)vs › | $311.25M | 34.00 | 44.34 | 25.02 | 19.51 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $348.63M | 3.87 | 3.84 | 4.42 | 6.10 |
| Agenus Inc. (AGEN)vs › | $350.42M | 0.34 | 0.31 | 0.53 | 0.83 |
| Standard BioTools Inc. (LAB)vs › | $305.38M | 8.80 | 4.55 | 3.67 | 2.92 |
| Opus Genetics, Inc. (IRD)vs › | $359.16M | 12.19 | 4.83 | 10.20 | 8.85 |
Quick Ratio
5.45
Excludes inventory
Current Ratio
5.45
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.45 |
| 2026-03-31 | 9.00 |
| 2025-12-31 | 7.81 |
| 2025-09-30 | 5.76 |
| 2025-06-30 | 5.06 |
| 2025-03-31 | 5.70 |
| 2024-12-31 | 5.71 |
| 2024-09-30 | 6.31 |
| 2024-06-30 | 5.09 |
| 2024-03-31 | 5.08 |
| 2023-12-31 | 6.34 |
| 2023-09-30 | 7.39 |
| 2023-06-30 | 5.69 |
| 2023-03-31 | 7.07 |
| 2022-12-31 | 6.46 |
| 2022-09-30 | 7.19 |
| 2022-06-30 | 6.90 |
| 2022-03-31 | 6.45 |
| 2021-12-31 | 6.36 |
| 2021-09-30 | 8.47 |
| 2021-06-30 | 10.81 |
| 2021-03-31 | 8.55 |
| 2020-12-31 | 8.69 |
| 2020-09-30 | 5.22 |
| 2020-06-30 | 6.49 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.88 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
